PMID- 31207167 OWN - NLM STAT- MEDLINE DCOM- 20200115 LR - 20210109 IS - 2050-4527 (Electronic) IS - 2050-4527 (Linking) VI - 7 IP - 3 DP - 2019 Sep TI - The allergic phenotype during the first 10 years of life in a prospective cohort. PG - 170-182 LID - 10.1002/iid3.255 [doi] AB - BACKGROUND: Heredity and environmental parameters jointly affect allergy development. Here, we used a Swedish prospective cohort to study the influence of heredity and factors usually associated with allergic disease and the development of allergic manifestations in combination with immunoglobulin E (IgE) sensitization at four different time points until 10 years of age. METHODS: Parents-to-be were characterized concerning allergy and their children (n = 281) were divided based on allergic heredity and followed from birth and clinically examined for IgE-associated allergic symptoms until 10 years of age. The relation between allergy and early-life parameters was analyzed by logistic regression. Group-wise comparisons were made by nonparametrical tests. RESULTS: Early life eczema and/or asthma in combination with IgE sensitization, was a strong indicator of allergy at a later time point. Further, the early occurrence of multiple allergic symptoms among IgE-sensitized children predisposed for a more complex allergic phenotype at later ages, independently of allergic heredity. At 10 years of age, allergic children had higher fractional exhaled nitrogen oxide (FeNO) levels, regardless of asthma, and FeNO levels were also influenced by heredity. Birth season was strongly associated with allergy development, but only in children with two allergic parents. CONCLUSION: Allergic eczema/asthma in early life, being born during the autumn/winter, having multiple allergic symptoms and two allergic parents were all strong predictors for having allergic diseases at 5 and 10 years of age. However, the allergic march seems to be independent of heredity, as IgE-mediated allergies follow the same trajectories in children with and without allergic heredity. CI - (c) 2019 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd. FAU - Bjorkander, Sophia AU - Bjorkander S AD - Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden. FAU - Hallberg, Jenny AU - Hallberg J AD - Department of Clinical Science and Education, Sodersjukhuset, Karolinska Institutet, Stockholm, Sweden. AD - Sachs' Children and Youth Hospital, Stockholm, Sweden. AD - Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. FAU - Persson, Jan-Olov AU - Persson JO AD - Department of Mathematics, Stockholm University, Stockholm, Sweden. FAU - Lilja, Gunnar AU - Lilja G AD - Department of Clinical Science and Education, Sodersjukhuset, Karolinska Institutet, Stockholm, Sweden. AD - Sachs' Children and Youth Hospital, Stockholm, Sweden. FAU - Nilsson, Caroline AU - Nilsson C AD - Department of Clinical Science and Education, Sodersjukhuset, Karolinska Institutet, Stockholm, Sweden. AD - Sachs' Children and Youth Hospital, Stockholm, Sweden. FAU - Sverremark-Ekstrom, Eva AU - Sverremark-Ekstrom E AUID- ORCID: 0000-0001-6271-8681 AD - Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190617 PL - England TA - Immun Inflamm Dis JT - Immunity, inflammation and disease JID - 101635460 RN - 31C4KY9ESH (Nitric Oxide) RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Age Factors MH - Asthma/diagnosis/*immunology MH - Child MH - Child, Preschool MH - Eczema/diagnosis/*immunology MH - Exhalation MH - Female MH - Humans MH - Hypersensitivity/diagnosis/*immunology MH - Immunoglobulin E/*immunology MH - Infant MH - Infant, Newborn MH - Male MH - Nitric Oxide/immunology/metabolism MH - Parents MH - Phenotype MH - Prospective Studies PMC - PMC6688083 OTO - NOTNLM OT - FeNO OT - allergy OT - birth season OT - childhood OT - early predictors of allergy OT - lung function OT - parental allergy OT - prospective cohort COIS- The authors declare that there are no conflict of interests. EDAT- 2019/06/18 06:00 MHDA- 2020/01/16 06:00 PMCR- 2019/06/17 CRDT- 2019/06/18 06:00 PHST- 2019/03/12 00:00 [received] PHST- 2019/05/09 00:00 [revised] PHST- 2019/05/16 00:00 [accepted] PHST- 2019/06/18 06:00 [pubmed] PHST- 2020/01/16 06:00 [medline] PHST- 2019/06/18 06:00 [entrez] PHST- 2019/06/17 00:00 [pmc-release] AID - IID3255 [pii] AID - 10.1002/iid3.255 [doi] PST - ppublish SO - Immun Inflamm Dis. 2019 Sep;7(3):170-182. doi: 10.1002/iid3.255. Epub 2019 Jun 17.